Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A phase 2 trial evaluating carboplatin with or without decitabine in progressive, advanced ovarian epithelial cancer, fallopian tube cancer,…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride in combination with tanespimycin for recurrent advanced ovarian epithelial cancer or prim…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial update of liposomal doxorubicin with carboplatin in patients with recurrent ovarian cancer, fallopian tube cancer, or…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of paclitaxel and celecoxib for recurrent or persistent platinum-resistant ovarian epith…
-
CLINICAL_TRIALS withdrawal · 2013-07-09Clinical Trial Update: Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial of nitrocamptothecin for recurrent or metastatic ovarian cancer and primary peritoneal cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating combination chemotherapy for newly diagnosed Stage III/IV ovarian cancer or primary peritoneal cancer has been te…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer [Phase 2]
Phase 2 trial evaluating intravenous denileukin diftitox plus subcutaneous pegylated interferon-alpha-2a in Stage III/IV ovarian-related can…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of docetaxel and carboplatin in patients with ovarian cancer, fallopian tube cancer, or …
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for TLK286 in advanced ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer; the st…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating topotecan in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors [Phase 1]
Phase 1 trial evaluating combination chemotherapy in previously untreated, newly diagnosed epithelial tumors, including endometrial cancer, …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
The document reports results from a completed Phase 2 trial of gefitinib in patients with recurrent or persistent ovarian epithelial cancer …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating capecitabine for recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [Phase 2]
Phase 2 trial of aminocamptothecin in recurrent or refractory ovarian epithelial cancer and primary peritoneal cancer completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
This Phase 2 trial evaluated the combination of cisplatin and irinotecan in patients with fallopian tube, ovarian, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy [Phase 2]
A Phase 2 trial of oxaliplatin for patients with recurrent or refractory ovarian epithelial cancer or primary peritoneal cancer that did not…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Gefitinib in Treating Patients With Cervical Cancer [Phase 2]
A Phase 2 clinical trial evaluating gefitinib in patients with cervical cancer and related gynecologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
This is a Phase 2 clinical trial update for irofulven in recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer. The …
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of carboxyamidotriazole for refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 1]
Phase 1 vaccine therapy trial for ovarian, fallopian tube, and primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1]
This document reports the completion of a Phase 1 trial evaluating taurolidine in patients with recurrent ovarian epithelial cancer, fallopi…
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum [Phase 2]
A Phase 2 trial evaluating the combination of bicalutamide and goserelin in ovarian cancer, fallopian tube cancer, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer [Phase 2]
This clinical trial update indicates the Phase 2 study of sorafenib tosylate plus gemcitabine hydrochloride in recurrent ovarian epithelial …
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [Phase 1]
A Phase 1 trial evaluating the combination of gemcitabine and topotecan for refractory or recurrent ovarian cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS withdrawal · 2013-06-10Clinical Trial Update: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin [Phase 2]
A Phase 2 trial of gemcitabine and carboplatin for persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peri…